153 related articles for article (PubMed ID: 2789388)
1. Major microheterogeneity of alpha 1-acid glycoprotein in management of patients with rheumatic diseases.
Mackiewicz A; Pawłowski T
Prog Clin Biol Res; 1989; 300():219-22. PubMed ID: 2789388
[No Abstract] [Full Text] [Related]
2. Minor microheterogeneity of alpha 1-acid glycoprotein in rheumatoid arthritis.
Pawłowski T; Mackiewicz A
Prog Clin Biol Res; 1989; 300():223-6. PubMed ID: 2780629
[No Abstract] [Full Text] [Related]
3. [Determination of blood viscosity in rheumatic diseases].
Roques CF; Amigues H; Fournie A; Simon J; Guiraud R
Nouv Presse Med; 1977 Sep; 6(30):2686. PubMed ID: 409995
[No Abstract] [Full Text] [Related]
4. Serum proteins--transferrin, ceruloplasmin, albumin, alpha 1-acid glycoprotein, alpha 1-antitrypsin--in rheumatic disorders.
Denko CW; Gabriel P
J Rheumatol; 1979; 6(6):664-72. PubMed ID: 316826
[TBL] [Abstract][Full Text] [Related]
5. Erythrocyte sedimentation rate within rheumatic disease clinics.
Giacomello A; Quaratino CP; Zoppini A
J Rheumatol; 1997 Nov; 24(11):2263-5. PubMed ID: 9375897
[No Abstract] [Full Text] [Related]
6. Protein SAP (serum amyloid P-component) in Waldenström's macroglobulinaemia, multiple myeloma and rheumatic diseases.
Strachan AF; Johnson PM
J Clin Lab Immunol; 1982 Sep; 8(3):153-6. PubMed ID: 6813503
[TBL] [Abstract][Full Text] [Related]
7. Glycosylation of alpha 1-acid glycoprotein in systemic onset juvenile rheumatoid arthritis and acute bacterial infection: value in differential diagnosis.
Fassbender K; Michels H; Zepp F; Zimmerli W; Aeschlimann A; Mackiewicz S; Müller W
J Rheumatol; 1993 Jan; 20(1):123-7. PubMed ID: 8441143
[TBL] [Abstract][Full Text] [Related]
8. Glycosylation of alpha 1-acid glycoprotein in relation to duration of disease in acute and chronic infection and inflammation.
Fassbender K; Zimmerli W; Kissling R; Sobieska M; Aeschlimann A; Kellner M; Müller W
Clin Chim Acta; 1991 Dec; 203(2-3):315-27. PubMed ID: 1777991
[TBL] [Abstract][Full Text] [Related]
9. [Uric acid levels of the serum of healthy persons and patients with various rheumatic diseases].
Bośmanský K; Ondrasík M
Ter Arkh; 1987; 59(4):22-5. PubMed ID: 3495897
[TBL] [Abstract][Full Text] [Related]
10. [Changes in blood calcium, phosphorus and alkaline phosphatase levels in rheumatoid polyarthritis and other types of inflammatory rheumatism].
Bontoux D; Alcalay M; Reboux JF; Thomas P; Joyeux F; Hofnung D
Rev Rhum Mal Osteoartic; 1979 Jun; 46(6):389-95. PubMed ID: 315611
[TBL] [Abstract][Full Text] [Related]
11. Complementary activity of the blood in rheumatism and certain allied disorders.
KELLETT CE
Ann Rheum Dis; 1954 Sep; 13(3):211-8. PubMed ID: 13198055
[No Abstract] [Full Text] [Related]
12. [Labile globulins in the serum of patients with rheumatism and the major collagenoses].
Kudriavtsev IuN
Vopr Revm; 1971; 11(4):61-4. PubMed ID: 5316787
[No Abstract] [Full Text] [Related]
13. Studies on microheterogeneity of acute-phase proteins in rheumatoid arthritis by using crossed affinoimmuno-electrophoresis with free concanavalin A.
Pawłowski T; Mackiewicz A; Mackiewicz S
Behring Inst Mitt; 1986 Jun; (80):11-5. PubMed ID: 2428350
[TBL] [Abstract][Full Text] [Related]
14. Sugar printing rheumatic diseases: a potential method for disease differentiation using immunoglobulin G oligosaccharides.
Watson M; Rudd PM; Bland M; Dwek RA; Axford JS
Arthritis Rheum; 1999 Aug; 42(8):1682-90. PubMed ID: 10446868
[TBL] [Abstract][Full Text] [Related]
15. [Studies on the blood basophils in various arthropathies with special reference to gout].
Bäumer A; Westerhoff H
Z Rheumaforsch; 1966 Aug; 25(7):273-7. PubMed ID: 5300835
[No Abstract] [Full Text] [Related]
16. Diagnosis of rheumatic disease. 2. Laboratory tests.
Bluestone R
Postgrad Med; 1979 Mar; 65(3):78-81, 84-7. PubMed ID: 368740
[TBL] [Abstract][Full Text] [Related]
17. [ABO and Gm(a) blood group systems in rheumatic diseases].
Kruszewski K
Przegl Lek; 1966; 22(9):608-10. PubMed ID: 5297029
[No Abstract] [Full Text] [Related]
18. The relations between the antinuclear, rheumatoid and L.E.-cell factors in the systemic rheumatic diseases.
HALL AP; BARDAWIL WA; BAYLES TB; MEDNIS AD; GALINS N
N Engl J Med; 1960 Oct; 263():769-75. PubMed ID: 13710745
[No Abstract] [Full Text] [Related]
19. Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activity.
Gabay C; Cakir N; Moral F; Roux-Lombard P; Meyer O; Dayer JM; Vischer T; Yazici H; Guerne PA
J Rheumatol; 1997 Feb; 24(2):303-8. PubMed ID: 9034987
[TBL] [Abstract][Full Text] [Related]
20. [Activities of some lysosomal enzymes of human white blood cells in rheumatoid arthritis, lupus erythematosus and ankylosing spondylitis].
Fidelski R; Tchórzewski H; Niedworok J
Acta Haematol Pol; 1971; 2(3):229-34. PubMed ID: 5161837
[No Abstract] [Full Text] [Related]
[Next] [New Search]
